Gaebel W - Search Results

1

A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years.

Linden M, Godemann F, Gaebel W, Köpke W, Müller P, Müller-Spahn F, Pietzcker A, Tegeler J. Linden M, et al. Among authors: gaebel w. Schizophr Bull. 2001;27(4):585-96. doi: 10.1093/oxfordjournals.schbul.a006898. Schizophr Bull. 2001. PMID: 11824485 Clinical Trial.

2

Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of Germany.

Bandelow B, Müller P, Frick U, Gaebel W, Linden M, Müller-Spahn F, Pietzcker A, Tegeler J. Bandelow B, et al. Among authors: gaebel w. Eur Arch Psychiatry Clin Neurosci. 1992;241(5):291-5. doi: 10.1007/BF02195978. Eur Arch Psychiatry Clin Neurosci. 1992. PMID: 1351405 Clinical Trial.

3

Prospective study of course of illness in schizophrenia: Part III. Treatment and outcome.

Gaebel W, Pietzcker A. Gaebel W, et al. Schizophr Bull. 1987;13(2):307-16. doi: 10.1093/schbul/13.2.307. Schizophr Bull. 1987. PMID: 2887033

4

Prospective study of course of illness in schizophrenia: Part II. Prediction of outcome.

Gaebel W, Pietzcker A. Gaebel W, et al. Schizophr Bull. 1987;13(2):299-306. doi: 10.1093/schbul/13.2.299. Schizophr Bull. 1987. PMID: 3616521

5

Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?

Gaebel W, Frick U, Köpcke W, Linden M, Müller P, Müller-Spahn F, Pietzcker A, Tegeler J. Gaebel W, et al. Br J Psychiatry Suppl. 1993 Sep;(21):8-12. Br J Psychiatry Suppl. 1993. PMID: 8105814 Clinical Trial.

6

Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder.

Doering S, Müller E, Köpcke W, Pietzcker A, Gaebel W, Linden M, Müller P, Müller-Spahn F, Tegeler J, Schüssler G. Doering S, et al. Among authors: gaebel w. Schizophr Bull. 1998;24(1):87-98. doi: 10.1093/oxfordjournals.schbul.a033316. Schizophr Bull. 1998. PMID: 9502548

7

Prodromal states in schizophrenia.

Gaebel W, Jänner M, Frommann N, Pietzcker A, Köpcke W, Linden M, Müller P, Müller-Spahn F, Tegeler J. Gaebel W, et al. Compr Psychiatry. 2000 Mar-Apr;41(2 Suppl 1):76-85. doi: 10.1016/s0010-440x(00)80012-7. Compr Psychiatry. 2000. PMID: 10746908

8

The hypothalamic-pituitary-thyroid axis in patients with schizophrenia.

Baumgartner A, Pietzcker A, Gaebel W. Baumgartner A, et al. Among authors: gaebel w. Schizophr Res. 2000 Sep 1;44(3):233-43. doi: 10.1016/s0920-9964(99)00187-5. Schizophr Res. 2000. PMID: 10962225

9

Is interval medication a successful treatment regimen for schizophrenic patients with critical attitudes towards treatment?

Godemann F, Linden M, Gaebel W, Köpke W, Müller P, Müller-Spahn F, Tegeler J, Pietzcker A. Godemann F, et al. Among authors: gaebel w. Eur Psychiatry. 2003 Mar;18(2):82-4. doi: 10.1016/s0924-9338(03)00008-7. Eur Psychiatry. 2003. PMID: 12711404 Clinical Trial.

10

Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.

Bandelow B, Müller P, Gaebel W, Köpcke W, Linden M, Müller-Spahn F, Pietzcker A, Reischies FM, Tegeler J. Bandelow B, et al. Among authors: gaebel w. Eur Arch Psychiatry Clin Neurosci. 1990;240(2):113-20. doi: 10.1007/BF02189981. Eur Arch Psychiatry Clin Neurosci. 1990. PMID: 1981149 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters